Company / PP&E per Share
Charles River Laboratories PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$33.63
FY2025
5-year range
$25.94 / $33.63
FY2021-FY2025
Trend
+7.6%
vs FY2024
Sector context
#10 of 137
Health Care
What the data says
Among 137 Health Care companies, Charles River Laboratories is in the top 7% for pp&e per share. PP&E per Share has fluctuated over the past 10 years, ranging from $16.19 in FY2016 to $33.63 in FY2025.
Based on SEC 10-K filings.
33.63 in FY2025 with a 5-year CAGR of +7.9%. Top quartile in the Health Care sector.
Improved from $32.19 to $33.63 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +5.0%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 137This company $33.63 Sector average $11.49
▼
+192.7% above sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 7.6% year-over-year.
- Ranks #10 out of 137 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $33.63 | +7.6% |
| FY2024 | $31.24 | -2.9% |
| FY2023 | $32.19 | +10.9% |
| FY2022 | $29.03 | +11.9% |
| FY2021 | $25.94 | +12.9% |
| FY2020 | $22.98 | +18.7% |
| FY2019 | $19.35 | -1.7% |
| FY2018 | $19.68 | +19.2% |
| FY2017 | $16.51 | +2.0% |
| FY2016 | $16.19 | +13.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026